What happens after fingolimod discontinuation? A multicentre real-life experience
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
What happens after fingolimod discontinuation? A multicentre real-life experience
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-17
DOI
10.1007/s00415-021-10658-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of treatment on cellular immunophenotype in MS
- (2020) Maria Cellerino et al. Neurology-Neuroimmunology & Neuroinflammation
- Lymphocyte recovery after fingolimod discontinuation in patients with MS
- (2020) Sara Nagy et al. Neurology-Neuroimmunology & Neuroinflammation
- Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effective and safe
- (2019) Carmen Alcalá et al. JOURNAL OF NEUROLOGY
- Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study
- (2019) Jessica Frau et al. JOURNAL OF NEUROLOGY
- Different MRI patterns in MS worsening after stopping fingolimod
- (2019) Caterina Lapucci et al. Neurology-Neuroimmunology & Neuroinflammation
- Switching from fingolimod to alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis: Α case series
- (2019) Konstantinos Notas et al. Multiple Sclerosis and Related Disorders
- Clinical activity after fingolimod cessation: disease reactivation or rebound?
- (2018) J. Frau et al. EUROPEAN JOURNAL OF NEUROLOGY
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Factors Predictive of Severe Multiple Sclerosis Disease Reactivation After Fingolimod Cessation
- (2018) Ugur Uygunoglu et al. NEUROLOGIST
- Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
- (2017) Hanne Marie Bøe Lunde et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod
- (2017) Mahtab Ghadiri et al. Multiple Sclerosis Journal
- Severe disease exacerbations in patients with multiple sclerosis after discontinuing fingolimod
- (2017) Anna Członkowska et al. Neurologia i Neurochirurgia Polska
- Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod
- (2017) Mahtab Ghadiri et al. Multiple Sclerosis Journal
- Steering through complexity
- (2016) Bruce A.C. Cree et al. CURRENT OPINION IN NEUROLOGY
- Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment
- (2016) Stacy Ellen Hatcher et al. JAMA Neurology
- Severe disease reactivation in four patients with relapsing–remitting multiple sclerosis after fingolimod cessation
- (2015) Benjamin Berger et al. JOURNAL OF NEUROIMMUNOLOGY
- Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment
- (2015) Simon Faissner et al. Therapeutic Advances in Neurological Disorders
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy
- (2013) G Francis et al. Multiple Sclerosis Journal
- Rebound of Disease Activity After Withdrawal of Fingolimod (FTY720) Treatment
- (2012) Joachim B. Havla ARCHIVES OF NEUROLOGY
- Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients
- (2012) A. Ghezzi et al. JOURNAL OF NEUROLOGY
- Withdrawal of fingolimod treatment for relapsing–remitting multiple sclerosis: report of six cases
- (2012) Bahia Hakiki et al. Multiple Sclerosis Journal
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now